NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Chris Rogers
University of Bristol - Bristol / United Kingdom
Others
AD Scientific Index ID: 4322778
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Chris Rogers's MOST POPULAR ARTICLES
1-)
Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgeryGJ Murphy, BC Reeves, CA Rogers, SIA Rizvi, L Culliford, GD AngeliniCirculation 116 (22), 2544-2552, 200714372007
2-)
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trialU Chakravarthy, SP Harding, CA Rogers, SM Downes, AJ Lotery, ...Ophthalmology 119 (7), 1399-1411, 20128782012
3-)
Liberal or restrictive transfusion after cardiac surgeryGJ Murphy, K Pike, CA Rogers, S Wordsworth, EA Stokes, GD Angelini, ...New England Journal of Medicine 372 (11), 997-1008, 20158402015
4-)
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trialU Chakravarthy, SP Harding, CA Rogers, SM Downes, AJ Lotery, ...The Lancet 382 (9900), 1258-1267, 20138402013
5-)
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre …APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ...The Lancet 398 (10318), 2258-2276, 20217452021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept